SerOptix's team of scientists and physicians has created the Infectious
Disease-Laser Based System( ID-LBS ). This compact machine combines
recent advances in optical physics and spectrofluorometric analysis
to identify infectious disease in blood samples using microlasers.
The ID-LBS has the potential to change the way the nation's blood
supply is tested. The ID-LBS Analyzer will redefine blood screening.
The system's laser accuracy analyzes blood specimens in one minute
as opposed to current procedures that take days. Blood screening
centers, physician labs and individual patients will have the
answers they need immediately.
Collected blood specimens pumped into the ID-LBS Analyzer.
A microlaser illuminates the blood.
The resulting fluorescence is aquired by the spectrometer and
imaged on the cooled CCD camera.
The recorded spectrum is stored in the computer after each sample
is scanned, up to a maximum of 80 samples per run. (note: The
first four steps are based on a per sample time. The next steps
are dependent on the number of samples run. This is an estimate
of time based on an average per sample of 80 samples.)
00:33 SerOptix's patent pending algorithms and software analyze
the spectrum (i.e., measures intensity vs. wavelength). Unlike
other existing technology platforms, ID-LBS detects biochemical
changes in the blood rather than a direct assay of the virus.
The resulting information, in chart format, identifies the blood
as diseased or healthy. No human analysis of the charted information
is needed, since the computer generates a report documenting the
specimen ID number along with a positive or negative reading.